ClinicalTrials.Veeva

Menu

Microneedling for Burn Hypertrophic Scars

C

Centre hospitalier de l'Université de Montréal (CHUM)

Status

Enrolling

Conditions

Burn Scar

Treatments

Procedure: Microneedling

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Approximately 33 to 91% of severe burn victims will develop hypertrophic scars. Hypertrophic scars are defined as erythematous (red), raised and rigid scars that can cause pain and itching, among other things. They cause psychological distress and affect the quality of life of burn victims. Microneedling is a technique that uses an electrical device to create hundreds of microchannels that penetrate the skin layers. This study is interested in determining the effectiveness of microneedling in improving the pliability, thickness and erythema of hypertrophic scars. Each scar will receive up to 5 ACS-pen treatments followed by the application of cortisone (triamcinolone acetonide). Knowing that microneedling increases the absorption of products applied to the skin by about 80%, it is logical to think that creating these channels to the dermis and applying cortisone afterwards would have a beneficial effect on the hypertrophic scars of these patients.

Full description

Patients will receive microneedling once every six weeks for a maximum of five treatments

Enrollment

36 estimated patients

Sex

All

Ages

16 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any gender or race
  • 16 years of age or older
  • Have at least 2 HSc that meet the clinical criteria for HSc
  • Provide written informed consent.

Exclusion criteria

  • Patients with keloid scars
  • Mature scar site
  • A psychiatric condition or cognitive impairment that interferes with their ability to follow the treatment protocol
  • Dermatological conditions (i.e. psoriasis, eczema, etc.) in the area of the evaluation site
  • An allergy to ultrasound gel
  • On anticoagulant medications
  • Inability to understand English or French.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

36 participants in 2 patient groups

Microneedling treated scar
Experimental group
Description:
Microneedling
Treatment:
Procedure: Microneedling
Control scar
No Intervention group
Description:
No intervention, standard of care

Trial contacts and locations

1

Loading...

Central trial contact

Bernadette Nedelec

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems